Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Cassava Sciences Inc (SAVA)

Cassava Sciences Inc (SAVA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,781,825
  • Shares Outstanding, K 40,009
  • Annual Sales, $ 0 K
  • Annual Income, $ -6,330 K
  • 60-Month Beta 1.09
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 14.70
Trade SAVA with:

Options Overview

Details
  • Implied Volatility 138.55%
  • Historical Volatility 223.82%
  • IV Percentile 57%
  • IV Rank 19.89%
  • IV High 283.69% on 02/02/21
  • IV Low 102.51% on 05/14/21
  • Put/Call Vol Ratio 0.47
  • Today's Volume 19,778
  • Volume Avg (30-Day) 20,835
  • Put/Call OI Ratio 0.84
  • Today's Open Interest 138,078
  • Open Int (30-Day) 109,888

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.11
  • Number of Estimates 2
  • High Estimate -0.10
  • Low Estimate -0.12
  • Prior Year -0.05
  • Growth Rate Est. (year over year) -120.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
65.00 +23.05%
on 07/30/21
146.16 -45.28%
on 07/29/21
-10.07 (-11.18%)
since 07/02/21
3-Month
36.05 +121.86%
on 05/11/21
146.16 -45.28%
on 07/29/21
+33.18 (+70.90%)
since 04/30/21
52-Week
2.78 +2,776.98%
on 09/04/20
146.16 -45.28%
on 07/29/21
+76.81 (+2,423.03%)
since 07/31/20

Most Recent Stories

More News
Cassava Sciences Announces Conference Call for Second Quarter Financial Results

Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on Alzheimer's disease, will release financial results for the period ending June 30, 2021 on Tuesday, August 3, 2021 before the market...

SAVA : 79.98 (+15.03%)
S&P Rises More Than 2% in July

S&P Rises More Than 2% in July

SAVA : 79.98 (+15.03%)
DGRW : 61.20 (-0.16%)
DGRO : 51.62 (-0.12%)
CLS : 8.92 (+0.56%)
IGT : 18.98 (+1.23%)
SIMO : 76.28 (+1.72%)
GDYN : 21.24 (+0.90%)
AMZN : 3,331.48 (+0.12%)
PINS : 57.12 (-3.02%)
Cassava Sciences Announces Positive Biomarker Data with Simufilam in Alzheimer's Disease

-- Oral Presentation at AAIC Today

SAVA : 79.98 (+15.03%)
Cassava Sciences Announces Positive Cognition Data With Simufilam in Alzheimer's Disease

-- Cognition Improved 3.0 Points on ADAS-Cog at 9 Months (p

SAVA : 79.98 (+15.03%)
Five-Day Rally Ends While Waiting for Big Tech Reports

Five-Day Rally Ends While Waiting for Big Tech Reports

PRTY : 8.65 (+1.29%)
BRY : 5.61 (+1.08%)
ASIX : 33.59 (+0.42%)
HWC : 42.62 (-2.49%)
JBL : 59.13 (-0.69%)
NTAP : 80.13 (+0.68%)
LH : 297.61 (+0.49%)
LSCC : 57.09 (+0.60%)
RBC : 145.48 (-1.19%)
FDX : 276.16 (-1.35%)
UPS : 191.94 (+0.30%)
INCY : 78.47 (+1.45%)
STNE : 58.58 (-0.44%)
GDRX : 31.86 (-0.65%)
MAXR : 35.64 (-1.74%)
SAVA : 79.98 (+15.03%)
LVS : 41.51 (-1.98%)
GOOG : 2,719.79 (+0.57%)
AAPL : 145.52 (-0.23%)
MSFT : 284.82 (-0.03%)
FB : 351.95 (-1.22%)
PFE : 43.96 (+2.69%)
SHOP : 1,538.67 (+2.58%)
MCD : 240.10 (-1.08%)
BA : 225.34 (-0.50%)
Cassava Sciences Announces Positive Data with SavaDx from a Randomized Controlled Phase 2b Study of Simufilam

-- Simufilam 100 mg and 50 mg Reduced Plasma Levels of Altered Filamin A in Alzheimer's Patients 48% (p=0.003) and 44% (p=0.02) Respectively

SAVA : 79.98 (+15.03%)
Stocks Now Up for the Week After Second Day of Gains

Stocks Now Up for the Week After Second Day of Gains

TRMK : 29.42 (-2.00%)
VLRS : 21.90 (-0.82%)
DDS : 177.00 (-3.42%)
F : 13.91 (-0.29%)
TSLA : 709.67 (+3.27%)
LYFT : 56.00 (+1.23%)
BIDU : 166.61 (+1.59%)
APA : 18.28 (-2.51%)
COW : 38.07 (+0.18%)
BAL : 49.40 (unch)
SAVA : 79.98 (+15.03%)
INTC : 53.68 (-0.07%)
ABT : 120.92 (-0.05%)
DHR : 297.04 (-0.15%)
SNAP : 73.50 (-1.24%)
JNJ : 172.27 (+0.04%)
NFLX : 515.15 (-0.47%)
Cassava Sciences to Present New Clinical Dataset at 2021 Alzheimer's Association International Conference

- On Monday, July 26, New Clinical Data for SavaDx to be Shared in

SAVA : 79.98 (+15.03%)
Big Rebound as Fear Subsides and Netflix Reports

Big Rebound as Fear Subsides and Netflix Reports

ASPU : 6.44 (-2.28%)
MTDR : 29.78 (-3.62%)
NEP : 78.88 (+1.74%)
SIG : 65.40 (+1.65%)
PLBY : 28.86 (+2.41%)
MAXR : 35.64 (-1.74%)
GDRX : 31.86 (-0.65%)
DAL : 39.45 (-1.13%)
CHGG : 89.47 (+0.95%)
INCY : 78.47 (+1.45%)
MRVL : 60.57 (+0.10%)
STNE : 58.58 (-0.44%)
TMUS : 144.91 (+0.62%)
TRIP : 38.28 (+0.87%)
RAIL : 5.11 (-1.54%)
SAVA : 79.98 (+15.03%)
AA : 39.40 (-1.87%)
NFLX : 515.15 (-0.47%)
JNJ : 172.27 (+0.04%)
TXN : 190.72 (+0.05%)
CSX : 32.09 (-0.71%)
Cassava Sciences (SAVA) to Post Q2 Earnings: What's in Store?

Investors will be keen on updates from on its lead candidate, sumifilam, for Alzheimer's disease when Cassava (SAVA) reports Q2 results.

EXAS : 108.40 (+0.52%)
ACAD : 21.00 (-2.91%)
BPMC : 86.98 (-1.01%)
SAVA : 79.98 (+15.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Cassava Sciences Inc. is focused on the early detection and treatment of neurodegenerative diseases, such as Alzheimer's. Cassava Sciences Inc., formerly known as Pain Therapeutics Inc., is based in Austin, United States.

See More

Key Turning Points

3rd Resistance Point 98.32
2nd Resistance Point 92.66
1st Resistance Point 86.32
Last Price 79.98
1st Support Level 74.32
2nd Support Level 68.66
3rd Support Level 62.32

See More

52-Week High 146.16
Fibonacci 61.8% 91.39
Last Price 79.98
Fibonacci 50% 74.47
Fibonacci 38.2% 57.55
52-Week Low 2.78

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar